# A Study of BL1332 on Capsaicin-Induced Ocular Pain in Healthy Trial Participants

> **NCT07717918** · PHASE1 · COMPLETED · sponsor: **Bausch & Lomb Incorporated** · enrollment: 28 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BL1332 eye drops
- **DRUG:** BL1332 Placebo eye drops

## Key facts

- **NCT ID:** NCT07717918
- **Lead sponsor:** Bausch & Lomb Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2026-07-06
- **Primary completion:** 2026-08-05
- **Final completion:** 2026-08-05
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2026-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07717918

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07717918, "A Study of BL1332 on Capsaicin-Induced Ocular Pain in Healthy Trial Participants". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07717918. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*